Citigroup
AVNS icon

Citigroup’s Avanos Medical AVNS Stock Holding History

Citigroup’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,188
Closed -$34K – 7541
2015
Q3 		$34K Hold
1,188
– – ﹤0.01% 5678
2015
Q2 		$48K Sell
1,188
-156
-12% -$7K ﹤0.01% 5557
2015
Q1 		$66K Sell
1,344
-8,832
-87% -$409K ﹤0.01% 5339
2014
Q4 		$463K Buy
+10,176
New +$400K ﹤0.01% 3958

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Citigroup's AVNS Position: Q1 2026 in Review

Citigroup reduced its Avanos Medical (AVNS) stake by 35% in Q1 2026, selling an estimated $73.5K and leaving 10,344 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #4133.

Citigroup first reported a position in AVNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $3.86M in Q4 2017. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Citigroup held 10,344 shares of Avanos Medical worth $145K as of Q1 2026.
  • Citigroup sold 5,454 Avanos Medical shares in Q1 2026, an estimated $73.5K.
  • Avanos Medical made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4133 holding.
  • Citigroup first reported a position in Avanos Medical in Q4 2014 and has held it in 46 quarters since.
  • Citigroup's Avanos Medical position peaked at $3.86M in Q4 2017.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.